6990 — Sichuan Kelun-Biotech Biopharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- HK$43.25bn
- HK$40.14bn
- CNY1.54bn
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 81.8 | 93 | 2,488 |
Net Total Accounts Receivable | |||
Net Total Receivables | 70.6 | 104 | 124 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 298 | 332 | 2,807 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 514 | 658 | 701 |
Net Intangible Assets | |||
Total Assets | 813 | 993 | 3,510 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 3,445 | 4,167 | 1,110 |
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 3,457 | 4,219 | 1,180 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | -2,644 | -3,226 | 2,329 |
Total Liabilities & Shareholders' Equity | 813 | 993 | 3,510 |
Total Common Shares Outstanding |